Jana Portnow

Jana Portnow

UNVERIFIED PROFILE

Are you Jana Portnow?   Register this Author

Register author
Jana Portnow

Jana Portnow

Publications by authors named "Jana Portnow"

Are you Jana Portnow?   Register this Author

28Publications

1076Reads

25Profile Views

Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer.

Breast Cancer Res 2019 11 8;21(1):119. Epub 2019 Nov 8.

Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1202-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839083PMC
November 2019

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

J Transl Med 2018 06 29;16(1):179. Epub 2018 Jun 29.

Northwest Biotherapeutics Inc., Bethesda, MD, USA.

View Article

Download full-text PDF

Source
https://translational-medicine.biomedcentral.com/articles/10
Publisher Site
http://dx.doi.org/10.1186/s12967-018-1552-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026340PMC
June 2018

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.

N Engl J Med 2016 12;375(26):2561-9

From the Department of Hematology and Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory (C.E.B., D.A., R.S., L.W., J.R.W., A.N., J.R.O., A.K., S.J.P., X.W., S.J.F.), and the Departments of Information Sciences (M.S.B.), Clinical Research (J.K., J.S.), Neurosurgery (T.L.H., M.C., B.B.), Pathology (M.D.), Diagnostic Radiology (J.A.R.), Developmental and Stem Cell Biology (M.E.B.), and Medical Oncology and Therapeutics Research (J.P.), City of Hope Beckman Research Institute and Medical Center, Duarte, CA; and the Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle (M.C.J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1610497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390684PMC
December 2016

Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.

Neuro Oncol 2016 08 2;18(8):1137-45. Epub 2016 Feb 2.

Brigham and Women's Hospital/Harvard Medical School, Massachusetts (L.A.W., E.A.C.); Advantagene, Inc., Auburndale, Massachusetts (A.G.M., L.K.A., E.A.-C.); Ohio State University, Columbus, Ohio (S.D.B., R.C., J.M.M., J.C.G., H.B.N.); University Hospitals Seidman Cancer Center/ Case Western Reserve University, Cleveland, Ohio (S.S.L.); City of Hope, Duarte, California (B.B., J.B.); Houston Methodist Hospital, Houston, Texas (B.S.T., T.W.T., D.S.B., P.Z.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933478PMC
August 2016

Central Nervous System Cancers, Version 1.2015.

J Natl Compr Canc Netw 2015 Oct;13(10):1191-202

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Yale Cancer Center/Smilow Cancer Hospital; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; University of Michigan Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; American Brain Tumor Association; Vanderbilt-Ingram Cancer Center; Mayo Clinic Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Cancer Institute; Fred & Pamela Buffet Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/10/1191.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2015.0148DOI Listing
October 2015

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2014 Nov;12(11):1517-23

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; American Brain Tumor Association; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337873PMC
http://dx.doi.org/10.6004/jnccn.2014.0151DOI Listing
November 2014

Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development.

Expert Opin Drug Metab Toxicol 2010 Dec 23;6(12):1477-91. Epub 2010 Oct 23.

Johns Hopkins University, Neurosurgery and Oncology, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2010.523420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994531PMC
December 2010

The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.

Clin Cancer Res 2009 Nov 27;15(22):7092-8. Epub 2009 Oct 27.

Department of Medical Oncology and Experimental Therapeutics, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908372PMC
November 2009

The quality of life of patients with malignant gliomas and their caregivers.

Soc Work Health Care 2008 ;47(4):455-78

Center for Neurosciences, Department of Utilization Management and Social Work, Huntington Hospital, Pasadena, California 91206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00981380802232396DOI Listing
March 2009

Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy.

Cancer Genomics Proteomics 2008 May-Aug;5(3-4):151-60

Department of Clinical & Molecular Pharmacology, City of Hope National Cancer Center, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
October 2008

Assessment of pain caused by invasive procedures in cancer patients.

J Natl Compr Canc Netw 2003 Jul;1(3):435-9

Department of Medical Oncology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2003.0037DOI Listing
July 2003